drugset / Trial / NCT03297814
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
RandomizedParallel-groupTriple-blindTreatment
Summary
Allogenic platelet lysate will be injected in the gastrocnemius of patients with peripheral arterial disease (PAD)
Timeline
- Start
- 2018-04-18
- Primary completion
- 2020-03
- Completion
- 2020-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Platelet Lysate | Unknown | 5 ml | Intramuscular |